Xilio Therapeutics (XLO) announced the appointment of Cheryl Blanchard, Ph.D. to the company’s board of directors. The company also announced that Christina Rossi has stepped down from its board of directors, effective April 15, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XLO:
- Upcoming Stock Splits This Week (March 16–20, 2026) – Stay Invested
- Xilio Therapeutics Inc trading halted, news pending
- Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
- Xilio Therapeutics announces 1-for-14 reverse stock split
- Xilio Therapeutics Updates Investor Presentation on I-O Strategy